Anxiety and PTSD linked to increased myelin in brain’s gray matter

fMRI images of brain of veteran with PTSD


An fMRI scan of the brain of a military veteran with PTSD, showing gray matter regions with increased myelin CREDIT UCSF image by Linda Chao

A recent study links anxiety behavior in rats, as well as post traumatic stress disorder (PTSD) in military veterans, to increased myelin — a substance that expedites communication between neurons — in areas of the brain associated with emotions and memory.

The results, reported by scientists at the University of California, Berkeley, and UC San Francisco (UCSF), provide a possible explanation for why some people are resilient and others vulnerable to traumatic stress, and for the varied symptoms — avoidance behavior, anxiety and fear, for example — triggered by the memory of such stress.

If, as the researchers suspect, extreme trauma causes the increased myelination, the findings could lead to treatments — drugs or behavioral interventions — that prevent or reverse the myelin production and lessen the aftereffects of extreme trauma.

Myelin is a layer of fatty substances and proteins that wraps around the axons of neurons — essentially, the insulation around the brain’s wiring — to facilitate long-distance transmission of signals and, thus, communication between distant areas of the brain. The inner regions of the brain look white — in fact, they are referred to as “white matter” — because of the myelin encasing the many large bundles of axons there.

But the new study finds increased myelination of axons in so-called “gray matter,” where most of the cell bodies of neurons reside and most of the wiring is less insulated with myelin. The extra myelination was found primarily in areas associated with memory.

Researchers at the San Francisco Veterans Affairs Medical Center conducted brain MRI scans of 38 veterans — half with PTSD, half without — and found an increase in myelination in the gray matter of those with PTSD compared to that seen in the brains of those not suffering from PTSD.

Colleagues at UC Berkeley, meanwhile, discovered a similar increase in myelination in the gray matter of adult rats subjected to an acute stressful event. While not all rats showed long-term effects from the stress — just as not all traumatized veterans develop PTSD — those that did had increased myelination in specific areas of the brain associated with particular symptoms of stress that was identical to what UCSF physicians found in veterans with PTSD.

Both veterans with PTSD and stressed rats that exhibited avoidance behavior, for example, had increased myelination in the hippocampus, often thought of as the seat of memory. Those exhibiting a fear response had increased myelination in the amygdala, which plays a key role in our response to strong emotions, such as fear or pleasure. Those suffering from anxiety had increased myelination in the dentate gyrus, a region critical to learning and memory.

“The combination of these studies in rats with our population of veterans with post traumatic stress disorders is, to me, really exciting,” said senior author Dr. Thomas Neylan, director of the Posttraumatic Stress Disorders (PTSD) Clinic and the Stress and Health Research Program at the San Francisco VA. “At least it’s another mechanism to think about as we develop new treatments. If we see enduring ability to shape myelin content in an adult brain, maybe treatments will help reverse this. That’s where we want to go next with this.”

People — and rats — vary in their response to stress

The correlation between the symptoms and the region of myelination was discovered because UC Berkeley researchers subjected the rats to a battery of more than a dozen tests to assess their specific behavioral response to acute stress.

“We understand that there’s a lot of individual variation in humans, but with rats, they’re genetically identical, so you think when you expose them to stress you’re going to get the same response,” said senior author Daniela Kaufer, UC Berkeley professor of integrative biology. “But the response is extremely variable. They sort of fall into groups, such that some are really resilient, and some are vulnerable. And the ones that are vulnerable are vulnerable in different ways: Some show avoidance behavior, and some show fear learning problems, and some show startle responses that are exaggerated.”

According to Neylan, similar individuality is seen in people with PTSD. The new study suggests that the specific symptoms are related to which areas of the brain are being newly myelinated.

“There’s a lot of heterogeneity across different people with PTSD; it’s not one size fits all. Every PTSD patient generally has a mix of different symptoms,” said Neylan, professor-in-residence in psychiatry at the UC San Francisco Weill Institute for Neurosciences. “Some people are very avoidant. Some people are very hyperreactive. The idea is that if you can show that these different symptom clusters have different neural circuitry, it might actually lead us closer to subtyping people in a way that we could be more targeted in our treatment.”

The researchers, who published their results in December 2021 in the journal Translational Psychiatry, show that stress produces more of the brain’s glial cells, called oligodendrocytes, which wrap around the axons of neurons and make the myelin. The increased myelin produced by these new oligodendrocytes could affect the speed of connections between neurons, making some connections hyperresponsive.

“In the gray matter of your cortex, most of the dendrites and axons — the projections that come out of the neurons that help establish communications with other neurons — can form thousands of connections, and most of them are unmyelinated,” Neylan said. “But if experience leads you to start to lay down myelin to strengthen certain connections, let’s say your ability to respond quickly to a fearful stimulus, you can speed up that circuit, but you lose the kind of broader adaptive flexibility that you normally would have with mostly unmyelinated axons and dendrites. People with PTSD become almost like a one-note musician — they really know how to respond to fear. But that enhanced, quick response to fear may diminish their adaptive flexibility for non-fear-type behavior.”

Acute stress boosts oligodendrocytes

In 2014, Kaufer and her UC Berkeley colleagues discovered that rats subjected to acute stress produced more oligodendrocytes in the brain’s gray matter — specifically, in the hippocampus. She proposed that this led to increased myelination of axons, potentially interfering with the speed at which signals traveled between different areas of the gray matter of the brain, such as the hippocampus and the amygdala. The new study bolsters that theory.

Neylan was intrigued by the 2014 findings and contacted Kaufer, and they’ve been collaborating ever since. Neylan teamed up with Linda Chao, UCSF professor of radiology, who developed a way to image myelin in the gray matter of the brain, and several years ago scanned the brains of 38 veterans who had experienced severe trauma, some with and some without PTSD.

At the time, scientists looking for changes in myelination related to brain disorders were focused on the cortex’s white matter, which is mostly myelinated. In multiple sclerosis, for example, an autoimmune attack destroys myelin in the white matter. Kaufer was perhaps the first to find evidence of increased myelination in the gray matter associated with disease.

Chao and Neylan did find increased myelination of neurons in the gray matter of veterans with PTSD, but not in those without PTSD. The worse the symptoms, the greater the myelination.

This led Kaufer and first author Kimberly Long, now a UCSF postdoctoral fellow, to see if they could also find increased myelin in gray matter after acute trauma in rats. After they focused on the specific symptoms of individual rats with PTSD, they found a correlation between symptoms and myelination in specific regions of the gray matter.

Chao subsequently reanalyzed the brain scans of her earlier group of 38 veterans and found the same correlation: Specific symptoms were associated with myelination in one region of gray matter, but not others.

Long and Kaufer then employed a type of viral gene therapy to rev up a transcription factor, called olig1, that increases the production of oligodendrocytes from stem cells in the gray matter. When Long injected the virus into the dentate gyrus of rats, the researchers found that this boosted the number of oligodendrocytes and generated symptoms of avoidance, even without any stress.

“The next question was, ‘If I change oligodendrocyte genesis, am I going to change behavior?” Kaufer said. “The beginning of an answer is here in this paper — it’s yes. And now, there’s a lot more to do to really understand that.”

Neylan, Chao and Kaufer are collaborating on further studies, including looking for increased myelin in the brains of PTSD patients who have died, improving fMRI imaging of myelin in the brain, investigating the effects of chronic stress on the brain connections of rats, and using new high-resolution imaging to study the myelin deposition in gray matter.

The work was supported by a grant from National Institute of Mental Health of the National Institutes of Health (R01MH115020).

Other co-authors of the paper were undergraduates Yurika Kazama, Vivian Roan, Rhea Misra, Anjile An, Kelsey Hu, and Claire Toth and doctoral student Jocelyn Breton of UC Berkeley; UCLA undergraduate Lior Peretz; University of Arizona undergraduate Dyana Muller; University of British Columbia (UBC) doctoral student William Casazza; UBC professor Sara Mostafavi; Boston University neurologist Dr. Bertrand Huber; and researcher Steven Woodward of the VA Palo Alto Health Care System.

Helping people understand and track their health

MIT spinoff Fitnescity makes it easier for users to schedule health tests, work with physicians, and interpret results.

body health metrics graphic

Caption:Fitnescity makes monitoring personal health and wellness more manageable with a platform that helps users schedule tests and interpret results.Credits:Image: Courtesy of Fitnescity, edited by MIT News

Laila Zemrani

Caption:“We’re making navigating personal health a lot easier,” says Fitnescity CEO Laila Zemrani MBA ’13.Credits:Image: Mark Kessell

app dashboard

Caption:A screenshot from the Fitnescity app.Credits:Image: Courtesy of Fitnescity

About half of all women over 50 will experience a broken bone at some point. Those injuries can lead to major setbacks in function and independence from which some patients never fully recover. Fortunately, maintaining bone density can prevent such injuries. One way to maintain bone health is by getting adequate levels of calcium and vitamin D. That’s why many people want to track nutrient levels and bone density before they wind up in a hospital.

But the process for scheduling such tests requires people to find nearby clinics, pay insurance deductibles or out-of-pocket costs, and then look through complex, paper-based results to identify deficiencies. Tracking changes over time — in order to see how a new diet is affecting nutrition levels, for instance — can be even more difficult.

Fitnescity aims to make health and wellness monitoring more manageable by providing access to in-person lab testing and visual analytics. The company’s platform aggregates testing clinics and enables people to easily find, schedule, and pay for tests. It also presents results to users in a way that is easy to understand. Over time, Fitnescity can also show users trends to help them understand how diet and lifestyle changes are impacting their health.

“We’re making navigating personal health a lot easier,” says Fitnescity CEO Laila Zemrani MBA ’13, who co-founded the company with Çağatay Demiralp, a former visiting researcher with the Data Systems Group at MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL). “Making healthy lifestyle changes is already a lot of work. The last thing people want to do is spend hours on Google figuring out what kind of clinic to go to and how to use their results.”

Fitnescity has partnered with hundreds of clinics across the U.S. to offer tests measuring nutrition levels, fitness, metabolic performance, stress, and more. Such tests can offer crucial insights for preventing diseases and injuries that may only present themselves after years of negative health trends.

“Today 80 percent of the most common and costly diseases in the U.S. are preventable — things like heart disease and type 2 diabetes,” Zemrani says. “You can often prevent these diseases by changing your lifestyle.”

In pursuit of an idea

Zemrani began classes at MIT’s Sloan School of Management in 2011.

I came to the U.S. for Sloan,” she says. “In my application, I was clear that I wanted to start a company here. For me, Sloan was the perfect place because it allowed me to get to the American market. And, as an immigrant new to the country you want to be immersed, but you also want to develop a network and learn the hard and soft skills for building a company.”

She also became a Legatum Center fellow and the co-president of the MIT Sloan Entrepreneurship Club. But she says the biggest benefit of MIT was the network she developed.

Zemrani first had the idea for Fitnescity following a difficult personal experience scheduling health tests. Around that time she met Demiralp through a mutual friend and the pair started building a platform to help people understand their test results.

In 2019, the co-founders secured a partnership with Mount Sinai Hospital in New York, where they helped schedule users’ first tests. From there they gradually expanded to other medical centers.

“It’s very replicable,” Zemrani says. “If it works in one location, you only need to bring that model to other locations nationally.”

Zemrani says there is a gap between underutilized testing equipment and a growing demand for tests from people trying to become healthier. By simplifying scheduling and reporting for consumers, Fitnescity allows local clinics and labs to reach more consumers.

For someone who is already in the market for a test, we’re the aggregator, and by aggregating we can offer a better experience, because the market is very fragmented,” Zemrani says.

When a test requires approval from a doctor, Fitnescity and its partners work with a national network of board-certified physicians to review test requests and results. The user can also speak with a physician about their results at no additional cost.

By making pricing transparent at local clinics, Zemrani says Fitnescity also helps users save money whether they’re going through insurance or not.

“We help you find and compare options,” Zemrani says. “The test could be something the consumer wants that’s not covered, or maybe it’s covered but it’s for someone who has a high deductible — which is the majority of the population.”

And as the company has grown, the founders’ MIT connections continue to pay dividends. Early on, Zemrani spent months researching companies like Quest Diagnostics and looking for opportunities for partnerships. Finally, she realized Quest’s CEO and executive vice president of general diagnostics were both Sloan alumni. She sent a cold email and was invited to the office to share more details about Fitnescity.

“I should have checked that in the beginning!” says Zemrani, who remains connected to MIT through a program with the Sandbox Innovation Fund that mentors startups in Morocco. “[Quest’s leadership] liked the vision of the company and they made the partnership happen, and basically what I was trying to accomplish for half a year happened that same day.”

A force for public health

Cardiovascular disease is the leading cause of death in America, accounting for about one in every four deaths in the country overall. Yet the Centers for Disease Control (CDC) estimates that 80 percent of cardiovascular disease is preventable.

With support from their doctors, many people are using tests like the ones on Fitnescity’s platform to be more proactive about their health. One Fitnescity user, for instance, lost both of her parents to heart disease within months of each other. The losses motivated her to adjust her lifestyle to reduce her own risk, in hopes her son could avoid the grief she was going through.

Fitnescity helped her schedule tests, including the Dual Energy X-Ray Absorptiometry (DEXA) scan, and track results. After months of diet and exercise changes, the tests showed that even though she wasn’t losing weight, she was losing visceral fat — a fat tied to several serious health complications — and gaining muscle mass, indicating her lifestyle changes were paying off.

The partnership with Quest, which was sparked by a meeting in 2019 but officially announced this October, is a game-changer for Fitnescity. It will open up thousands of Quest’s testing locations around the U.S. for Fitnescity’s users.

The Quest partnership will also help Fitnescity add testing capabilities. In the future, Zemrani sees Fitnescity expanding its offerings into more medical testing, like MRIs, that would be recommended by a doctor.

Ultimately, Zemrani believes Fitnescity is already helping to combat the growing health crisis in America.

“Our value is really about making sure you’re not just looking at your body when you’re sick, or if you’re healthy maybe once every year or two. We want to help you build a comprehensive and longitudinal view of your health, so you can see problems before they happen,” Zemrani says. “It’s a lot easier to prevent than it is to treat something when it’s already here.”

Evidence dyslexia affects children’s visual processing beyond just reading

Dyslexia study


A participant in the dyslexia study CREDIT University of Reading

Children with dyslexia are slower to process visual information, according to new research that sheds new light on which brain processes are affected by dyslexia beyond just reading ability.

The study, published in JNeurosci and the first to combine new methods to understand visual processing and brain activity in dyslexia, challenged a group of children aged six to 14 to identify the average direction of motion of a mass of moving dots, while their brain activity was measured.

It found children with dyslexia took longer to gather the visual evidence, and were less accurate, than their typically developing peers, and that the behavioural differences were reflected in differences in brain activity.

Although reading ability is known to be affected by dyslexia, researchers are still unclear on which brain processes are affected by the condition. Increasing understanding of this could potentially lead to more effective support for those affected.

Dr Cathy Manning, lead researcher in the Centre for Autism at the University of Reading, said: “These findings show that the difficulties faced by children with dyslexia are not restricted to reading and writing. Instead, as a group, children with dyslexia also show differences in how they process visual information and make decisions about it.

“Future research will be needed to see if these differences in visual processing and decision-making can be trained in order to improve reading ability in affected children, or provide clues as to the causes of dyslexia.”

Brain activity monitoring using EEG in the study showed synchronized activity over the centro-parietal regions of the brain involved in decision-making steadily increased in all of the children during the task until they made a decision. However, this happened more gradually in the children with dyslexia.

The study supports a link between motion processing and dyslexia, although the causes are not yet known.

Whether dyslexia is, at its core, a visual processing disorder is hotly debated among researchers. With reading and writing a key challenge among children with dyslexia, increasing understanding of its effects on the brain might aid how we improve existing interventions.

Why fasting bolsters brain power: Mark Mattson

How Intermittent Fasting Boosts Brain Power | Mark Mattson - YouTube


Mark Mattson is the current Chief of the Laboratory of Neurosciences at the National Institute on Aging. He is also a professor of Neuroscience at The Johns Hopkins University. Mattson is one of the foremost researchers in the area of cellular and molecular mechanisms underlying neurodegenerative disorders such as Alzheimer’s Disease, Parkinson’s Disease, and amyotrophic lateral sclerosis.

Ce face postul intermitent creierului și nu numai | Ileana Andrei